Clinical Trials Logo

Clinical Trial Summary

The use of a supplement food like "Nyaditum resae" is a reliable opportunity to stop the progression towards active TB through the most updated knowledge of this disease:the induction of tolerance.

In order to demonstrate the percentage of efficacy of this approach, different studies must be run to elucidate the percentage of protection in different setting all over the world. The strategy is to establish its efficacy through a simple clinical trial, aimed just to know the incidence of TB in Placebo and NR treated contacts of active TB cases.


Clinical Trial Description

Evaluation of a supplement food "Nyaditum resae" in the uincidence of TB. This is a ranzomized doube-blind controlled clinical trial to evaluate the efficacy and safety of a supplememt food in comparison to placebo in TB. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02897180
Study type Interventional
Source Fundació Institut Germans Trias i Pujol
Contact Pere-Joan Cardona, MD, PhD, Pr
Phone +34934978686
Email pj.cardona@igtp.cat
Status Recruiting
Phase Phase 2/Phase 3
Start date March 10, 2017
Completion date March 2021